- Home
- DRTS vs MYO Comparison
DRTS vs MYO Comparison
Compare DRTS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- MYO
- Stock Information
- Founded
- DRTS 2015
- MYO 2004
- Country
- DRTS Israel
- MYO United States
- Employees
- DRTS N/A
- MYO N/A
- Industry
- DRTS Medical/Dental Instruments
- MYO Industrial Specialties
- Sector
- DRTS Health Care
- MYO Health Care
- Exchange
- DRTS Nasdaq
- MYO Nasdaq
- Market Cap
- DRTS 159.1M
- MYO 157.9M
- IPO Year
- DRTS N/A
- MYO 2017
- Fundamental
- Price
- DRTS $3.09
- MYO $6.42
- Analyst Decision
- DRTS Strong Buy
- MYO Strong Buy
- Analyst Count
- DRTS 2
- MYO 4
- Target Price
- DRTS $8.00
- MYO $8.25
- AVG Volume (30 Days)
- DRTS 59.0K
- MYO 361.0K
- Earning Date
- DRTS 11-19-2024
- MYO 11-06-2024
- Dividend Yield
- DRTS N/A
- MYO N/A
- EPS Growth
- DRTS N/A
- MYO N/A
- EPS
- DRTS N/A
- MYO N/A
- Revenue
- DRTS N/A
- MYO $25,239,125.00
- Revenue This Year
- DRTS N/A
- MYO $53.19
- Revenue Next Year
- DRTS N/A
- MYO $39.01
- P/E Ratio
- DRTS N/A
- MYO N/A
- Revenue Growth
- DRTS N/A
- MYO 36.23
- 52 Week Low
- DRTS $1.75
- MYO $2.51
- 52 Week High
- DRTS $3.40
- MYO $6.75
- Technical
- Relative Strength Index (RSI)
- DRTS 69.66
- MYO 65.56
- Support Level
- DRTS $3.03
- MYO $5.84
- Resistance Level
- DRTS $3.20
- MYO $6.31
- Average True Range (ATR)
- DRTS 0.09
- MYO 0.47
- MACD
- DRTS -0.02
- MYO -0.04
- Stochastic Oscillator
- DRTS 65.62
- MYO 75.42
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).